BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1607342)

  • 1. A comparison between the Rappaport Classification and Working Formulation in cooperative group trials: the ECOG experience.
    Neiman RS; Cain K; Ben Arieh Y; Harrington D; Mann RB; Wolf BC
    Hematol Pathol; 1992; 6(2):61-70. PubMed ID: 1607342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New REAL clinical entities.
    Fisher RI; Miller TP; Grogan TM
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
    Teske E; Wisman P; Moore PF; van Heerde P
    Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphoma. A comparison of the working formulation with the Rappaport classification.
    Jose CC; Krishnaswami H; Oommen R; Rangad F; Roul RK; Singh AD
    Indian J Cancer; 1987 Jun; 24(2):99-106. PubMed ID: 3319895
    [No Abstract]   [Full Text] [Related]  

  • 5. [Non-Hodgkin's lymphoma: morphologic, immunologic and cytogenetic classification].
    Ristić S; Jovanović V; Ristić S; Radojković M
    Srp Arh Celok Lek; 1996; 124(9-10):276-82. PubMed ID: 9102863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical approach to the pathology of lymphoid neoplasms: a revised European-American classification from the International Lymphoma Study Group.
    Harris NL
    Important Adv Oncol; 1995; ():111-40. PubMed ID: 7672801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonconcurrence in abstracted diagnoses of non-Hodgkin's lymphoma.
    Dick FR; VanLier SF; McKeen K; Everett GD; Blair A
    J Natl Cancer Inst; 1987 Apr; 78(4):675-8. PubMed ID: 3470542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological classification of non-Hodgkin's lymphoma for epidemiological studies.
    Weisenburger DD
    Cancer Res; 1992 Oct; 52(19 Suppl):5456s-5462s; discussion 5462s-5464s. PubMed ID: 1394154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histopathologic classification of non-Hodgkin's lymphomas: ambiguities in the working formulation and two newly reported categories.
    Burke JS
    Semin Oncol; 1990 Feb; 17(1):3-10. PubMed ID: 2406915
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reproducibility and prognostic value of histopathological classifications of malignant lymphomas. Prolegomena for the 1st international classification proposed by WHO. Group of the non-Hodgkin's Malignant Lymphoma Classification Project].
    Diebold J; Weisenburger D; MacLennan KA; Müller-Hermelink HK; Nathwani BN; Harris NL; Anderson JR; Roy P; Armitage JO
    Bull Acad Natl Med; 1998; 182(7):1537-48; discussion 1548-9. PubMed ID: 9916346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma in a south Indian Hospital--our experience with the International Working Formulation.
    Nair S; Krishnaswami H
    Indian J Pathol Microbiol; 1990 Jan; 33(1):17-22. PubMed ID: 2394472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomas.
    Ezdinli EZ; Costello W; Wasser LP; Lenhard RE; Berard CW; Hartsock R; Bennett JM; Carbone PP
    Cancer; 1979 Feb; 43(2):544-50. PubMed ID: 369677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathology of malignant lymphomas].
    Yamabe H
    Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation.
    Carter RF; Valli VE; Lumsden JH
    Can J Vet Res; 1986 Apr; 50(2):154-64. PubMed ID: 3756669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO non-Hodgkin's lymphoma classification by criterion-based report review followed by targeted pathology review: an effective strategy for epidemiology studies.
    Turner JJ; Hughes AM; Kricker A; Milliken S; Grulich A; Kaldor J; Armstrong B
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2213-9. PubMed ID: 16172234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classification of malignant lymphomas].
    Murohashi I
    Rinsho Byori; 2001 Mar; Suppl 115():54-63. PubMed ID: 11391937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The World Health Organization classification of lymphomas.
    Jakić-Razumović J; Aurer I
    Croat Med J; 2002 Oct; 43(5):527-34. PubMed ID: 12402390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
    Kalyan K; Basu D; Soundararaghavan J
    Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of three pathologic classifications (Rappaport, LSG and Working Formulation) for the treatment of non-Hodgkin's lymphoma].
    Shibuya H; Kamiyama R; Umehara I; Okada Y; Sato S; Yoshimatsu S; Horiuchi J; Suzuki S
    Gan No Rinsho; 1985 Nov; 31(14):1757-61. PubMed ID: 4087381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapy of non-Hodgkin's lymphomas. Introduction and overview.
    Vose JM; Bierman PJ; Weisenburger DD; Armitage JO
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):845-52. PubMed ID: 1938757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.